The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA).
Hypertrophic pulmonary osteoarthropathy (HPOA) secondary to bronchogenic carcinoma can be associated with severe, disabling pain which is not always responsive to conventional treatment. To report on the use of pamidronate to control resistant pain in HPOA in three cases. A retrospective review of reported pain, chest X-ray and radionuclide bone scans was made. Pain relief was achieved in all three cases together with reduced radiolabel uptake in two cases. Pamidronate appears to be an effective therapy for HPOA. Further investigation is warranted.